Skip to main content

Table 1 Anthropometrics, hemodynamics, medication use, and fasted state in patients with or without coronary microvascular dysfunction (CMD)

From: Standard exercise stress testing attenuates peripheral microvascular function in patients with suspected coronary microvascular dysfunction

 

No CMD

CMD

All Patients

Non-EX

Exercisers

All Patients

Non-EX

Exercisers

n

34

21

13

42

25

17

Sex, male, n (%)

13 (38)

7 (33)

6 (46)

13 (31)

8 (32)

5 (29)

Age (years)

55 ± 13

58 ± 13

51 ± 13

60 ± 13

62 ± 13

57 ± 11

Body mass (kg)

81.8 ± 19.0

76.8 ± 18.4

90.0 ± 17.6

78.1 ± 15.4

79.1 ± 14.6

76.7 ± 16.8

Height (m)

1.69 ± 0.10

1.67 ± 0.10

1.73 ± 0.08

1.66 ± 0.10

1.66 ± 0.08

1.67 ± 0.12

BMI (kg/m2)

29 ± 6

27 ± 6

30 ± 6

28 ± 4

29 ± 4

27 ± 5

Resting SBP (mmHg)

124 ± 15

124 ± 18

124 ± 10

123 ± 12

126 ± 12

117 ± 11

Resting DBP (mmHg)

75 ± 8

76 ± 8

74 ± 8

76 ± 9

77 ± 9

74 ± 9

Resting HR (bpm)

67 ± 12

62 ± 9

74 ± 13a

68 ± 13

65 ± 13

72 ± 12a

Medication use, n (%)

 Anti-Hypertensive

21 (62)

13 (62)

8 (62)

35 (83)†

21 (84)

14 (82)

 Anti-Cholesterol

19 (56)

12 (57)

7 (54)

26 (62)

16 (64)

10 (59)

Fasted, n (%)

4 (12)

3 (14)

1 (8)

11 (26)

8 (32)

3 (18)

  1. Non-EX Non-Exercisers, CMD Coronary Microvascular Dysfunction, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, HR Heart Rate, BMI Body Mass Index. a indicates a significant exercise effect. † indicates a significant effect of CMD. Mean ± SD